Ocular inflammation induced by electroconvulsive treatment: Contribution of nitric oxide and neuropeptides mobilized from C-fibres

British Journal of Pharmacology

Volumn 120, Issue 8, 1997, Pages 1491-1496

  Wang, Zun Yi ^a   Waldeck, Kristian ^a   Grundemar, Lars ^a   Håkanson, Rolf ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

C fibres; Calcitonin gene related peptide; Electroconvulsive treatment; Nitric oxide; Ocular inflammation; Pituitary adenylate cyclase activating peptide; Rabbit eye; Seizure; Substance P; Transmitter release

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE 27; N(G) NITROARGININE METHYL ESTER; NEUROPEPTIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; SPANTIDE; SUBSTANCE P; TACHYKININ RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AQUEOUS HUMOR; ARTICLE; CONTROLLED STUDY; ELECTROCONVULSIVE THERAPY; EXTRAVASATION; EYE INFLAMMATION; HYPEREMIA; MIOSIS; NERVE FIBER C; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PUPIL;

EID: 0030937708     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701083     Document Type: Article

References (40)

1. ANJOU, C.I.N. & KRAKAU, C.E.T. (1961). Aqueous flare and protein content in the anterior chamber of normal rabbits' eyes. Acta Ophthalmol., 39, 95-101.
2. BEDING-BARNEKOW, B., BRODIN, E. & HÅKANSON, R. (1988). Substance P, neurokinin A and neurokinin B in the ocular response to injury in the rabbit. Br. J. Pharmacol., 95, 259-267.
3. BHAT, R.V., TAUSK, F.A., BARABAN, J.M., MAINS, R.E. & EIPPER, B.A. (1993). Rapid increases in peptide processing enzyme expression in hippocampal neurons. J. Neurochem., 61, 1315-1322.
4. 2, bradykinin and substance P. Br. J. Pharmacol., 69, 495-502
5. BUTLER, J.M., UNGER, W.G. & COLE, D.F. (1980). Axon reflex in ocular injury: sensory mediation of the response of the rabbit eye to laser irradiation of the iris. Q. J. Exp. Physiol., 65, 261-272.
6. BYNKE, G. (1983). Capsaicin pretreatment prevents disruption of the blood-aqueous barrier in the rabbit eye. Invest. Ophthalmol. Vis. Sci., 24, 744-748.
7. DYSTER-AAS, H.K. & KRAKAU, C.E.T. (1964). Aqueous flare determination in the rabbit by means of a minimal eye trauma. Invest. Ophthalmol., 3, 127-134.
8. FINK, M. (1987). Convulsive treatment in affective disorders. In Psychopharmacology: The Third Generation of Progress, ed. Meltzer, H.Y. pp. 1071-1076. New York: Raven Press.
9. GRUNDITZ, T., EKMAN, R., HÅKANSON, R., RERUP, C., SUNDLER, F. & UDDMAN, R. (1986). Calcitonin gene-related peptide in the thyroid nerve fibres and C cells: effects on thyroid hormone secretion and response to hypercalcemia. Endocrinology, 119, 2313-2324.
10. HÅKANSON, R., BEDING, B., EKMAN, R., HEILIG, M., WAHLESTEDT, C. & SUNDLER, F. (1987). Multiple tachykinin pools in sensory nerve fibres in the rabbit iris. Neuroscience, 21, 943-950.
11. HÅKANSON, R. & WANG, Z-Y. (1996). Sensory neuropeptides in the eye. In Neurogenic Inflammation, ed. Geppetti, P. & Holzer, P. pp. 131-140. Boca Raton: CRC Press Inc.
12. HALL, J.M., MITCHELL, D. & MORTON, I.K.M. (1991). Neurokinin receptors in the rabbit iris sphincter characterised by novel agonist ligands. Eur. J. Pharmacol., 199, 9-14.
13. HALL, J.M., MITCHELL, D. & MORTON, I.K.M. (1993). Tachykinin receptors mediating responses to sensory nerve stimulation and exogenous tachykinins and analogues in the rabbit isolated iris sphincter. Br. J. Pharmacol., 109, 1008-1013.
14. 7,9-SP, inhibits inflammatory responses in the rabbit eye. Science, 214, 1029-1031.
15. HOLZER, P. (1991). Capsaicin: cellular targets, mechanisms of action, and selectivity for thin sensory neurons. Pharmacol. Rev., 43, 143-201.
16. LINDEFORS, N., BRODIN, K., STILLER, C.-O., PERSSON, H. & BRODIN, E.R. (1991). Repeated electroconvulsive shock increases tachykinin and cholecystokinin mRNA expression in ventral periaqueductal gray. Neuroscience, 45, 73-80.
17. MIKKELSEN, J.D., WOLDBYE, D., KRAGH, J., LARSEN, P.J. & BOLWIG, T.G. (1994). Electroconvulsive shocks increase the expression of neuropeptide Y (NPY) mRNA in the piriform cortex and the dentate gyrus. Mol. Brain Res., 23, 317-322.
18. MOLLER, K., ZHANG, Y.-Z., HÅKANSON, R., LUTS, A., SJÖLUND B., UDDMAN, R. & SUNDLER, F. (1993). Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence. Neuroscience, 57, 725-732.
19. MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109-142.
20. MORRIS, R., SOUTHAM, E., BRAID, D.J. & GARTHWAITE, J. (1992). Nitric oxide may act as a messenger between dorsal root ganglion neurones and their satellite cells. Neurosci. Letts., 137, 29-32.
21. OSBORNE, N., BARNETT, N.L. & HERRERA, A.J. (1993). NADPH diaphorase localization and nitric oxide synthetase activity in the retina and anterior uvea of the rabbit eye. Brain Res., 610, 194-198.
22. PERSSON, M.G., WIKLUND, N.P. & GUSTAFSSON, L.E. (1991). Nitric oxide requirement for vasomotor nerve-induced vasodilatation and modulation of resting blood flow in muscle microcirculation. Acta Physiol. Scand., 141, 49-56.
23. G-nitro-L-arginine methyl ester on the cardiovascular system of the anaesthetized rabbit and on the cardiovascular response to thyrotropin-releasing hormone. Br. J. Pharmacol., 109, 1219-1225.
24. SNYDER, S.H. & BREDT, D.S. (1991). Nitric oxide as a neuronal messenger. Trends Pharmacol., 12, 125-128.
25. STENFORS, C., SRINIVASAN, G.R., THEODORSSON, E. & MATHE, A.A. (1992). Electroconvulsive stimuli and brain peptides: effect of modification of seizure duration on neuropeptide Y, neurokinin A, substance P and neurotensin. Brain Res., 596, 252-258.
26. STONE, R.A., KUWAYAMA, Y. & LATIES, A.M. (1987). Regulatory peptides in the eye. Experientia, 43, 791-800.
27. TERENGHI, G., POLAK, J.M., GHATEI, M.A., MULDERRY, P.K., BUTLER, J.M., UNGER, W.G. & BLOOM, S.R. (1985). Distribution and origin of calcitonin gene-related peptide (CGRP) immuno reactivity in the sensory innervation of the mammalian eye. J. Comp. Neurol., 233, 506-516.
28. TERVO, K., TERVO, T., ERÄNKÖ, O. & CUELLO, A.G. (1981). Immunoreactivity for substance P in the Gasserian ganglion, ophthalmic nerve and anterior segment of the rabbit eye. Histochem. J., 13, 435-443.
29. UNGER, W.G. (1990). Mediation of the ocular response to injury. J. Ocul. Pharmacol., 6, 337-353.
30. WAHLESTEDT, C., BEDING, B., EKMAN, R., OKSALA, O., STJERNSCHANTZ, J. & HÅKANSON, R. (1986). Calcitonin gene-related peptide in the eye: release by sensory nerve stimulation and effects associated with neurogenic inflammation. Regul. Pept., 16, 107-115.
31. WANG, Z.-Y., ALM, P. & HÅKANSON, R. (1995). Distribution and effects of pituitary adenylate cyclase-activating peptide in the rabbit eye. Neuroscience, 69, 297-308.
32. WANG, Z.-Y., ALM, P. & HÄKANSON, R. (1996a). The contribution of nitric oxide to endotoxin-induced ocular inflammation: interaction with sensory nerve fibres. Br. J. Pharmacol., 118, 1537-1543.
33. WANG, Z.-Y., FENG, D.-M., WANG, Y.-L., TUNG, S.R., WONG, K., STRICHARTZ, G.R., FOLKERS, K. & HÅKANSON, R. (1994a). Pharmacological assessment of spantide II analogues. Eur. J. Pharmacol., 260, 121-128.
34. 1 receptors only. Eur. J. Pharmacol., 216, 327-329.
35. WANG, Z.-Y. & HÅKANSON, R. (1992b). Effect of resiniferatoxin on the isolated rabbit iris sphincter muscle: comparison with capsaicin and bradykinin. Eur. J. Pharmacol., 213, 235-241.
36. 2 receptors: a study with selective agonists and antagonists. Regul. Pept., 44, 269-275.
37. WANG, Z.-Y. & HÅKANSON, R. (1995). Role of nitric oxide (NO) in ocular inflammation. Br. J. Pharmacol., 116, 2447-2450.
38. WANG, Z.-Y., MONSTEIN, H.-J. & HÅKANSON, R. (1996b). Release of preprotachykinin-A mRNA from rabbit iris upon C-fibre stimulation. Eur. J. Pharmacol., 297, 157-163.
39. 1 receptor anatagonist. Br. J. Pharmacol. 111, 1342-1346.
40. YAMAMOTO, R., BREDT, D.S., SNYDER, S.H. & STONE, R.A. (1993). The localization of nitric oxide synthase in the rat eye and related cranial ganglia. Neuroscience, 54, 189-195.